Miles and Pallets
Modes

Pharma Logistics Risks: Temperature Mishandling and Theft

An estimated 3-4% of pharmaceutical product is lost to temperature mishandling and theft, with fragmented data and evolving fraud tactics creating hidden

An estimated 3-4% of pharmaceutical product is lost to temperature mishandling and theft, with fragmented data and...

Pharma logistics faces hidden risks from temperature mishandling and theft, with an estimated 3% to 4% of product expired or destroyed in the supply chain. This loss often goes undetected until after delivery, despite widespread use of monitoring technology.

Why monitoring alone isn’t enough

GPS location data alone does not indicate whether temperature-sensitive cargo remains within required specifications. Todd Thompson, Director of Enterprise Sales at Overhaul, explained the gap: "GPS tells you where a truck is. It does not tell you whether the product inside still meets the temperature spec." A shipment can drift out of its required temperature range repeatedly during transit and still appear normal upon arrival if product temperatures recover before the receiver checks.

The human and systemic gaps in response

Modern sensors can generate excessive alerts, leading to fatigue among logistics teams that are often leaner than in the past. The real constraint during a disruption is rarely the event itself, but how fast and complete the condition data reaches the people who need to act. In mature cold chain programs, corrective actions and rerouting can happen in minutes, but a more typical response takes a few hours from alert to action.

Security breaches that mask as quality issues

Freight theft tactics are constantly evolving, with high-value temperature-controlled loads being frequent targets. The largest problems involve double brokering and deceptive 'chameleon' or 'phoenix' carriers. Practical signs of fraud include remarking, ghost lettering, taped-over signage, or zip-tied license plates on tractor-trailers.

When theft becomes a quality crisis

A security incident like tampering or diversion can trigger a major quality risk exposure. Logistics, security, and quality teams must then reconvene to decide if the product must be destroyed and to document how to prevent a recurrence. Visibility gaps enable compromised goods to re-enter the legitimate supply chain more often than shippers assume. Danny Ramon, Director of Security Intelligence and Response at Overhaul, noted, "Many shippers find out about the theft when their customer calls to ask when their shipment should arrive, far past any reasonable chance of recovery."

The complexity is immense. A single drug delivery to a pharmacy can involve roughly 50 different handlers. Entering pharma-regulated lanes requires significant upfront investment, including temperature mapping of reefer trailers and warehouses against seasonal extremes. Most setup costs occur before the first shipment, while revenue is measured per shipment, so carriers need sufficient volume to justify the entry. Food distribution operations often lack the recordkeeping infrastructure required for pharma, even if they run excellent food logistics.

Liability typically passes from the manufacturer to the first wholesaler and then down the chain. Pharma customers require a Technical Service Agreement backed by annual audits, and federal mandates include current Good Manufacturing Practices and 21 CFR Part 11 recordkeeping. The risks extend beyond pharmaceuticals. Humidity critically affects tobacco, while temperature and shock affect wine and spirits due to fragile packaging. Chemical shipments, like composite materials, require tight temperature bands to avoid premature curing or a shortened shelf life.

For food and beverage, Todd Thompson advises teams to audit one successful shipment by tracing the full custody record to identify gaps. On frozen goods, a partial thaw and refreeze may not be caught at the receiving dock but can cause failure later in use, such as in a fryer. Melita Marks, Cold Chain Market Advisor at Overhaul, notes that pharma manufacturers should move from manual temperature review to configurable alarm profiles that match specific drug stability data.

Topics

#Modes

Related coverage

More from Modes